Physician profile
Amy E Slama
NPI 1962758078
$3,230.24
in general payments reported to CMS, 2019-2025
16 companies · $103 in 2025
The $103 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,295 · 2020: $372 · 2021: $1,158 · 2022: $74.28 · 2023: $102 · 2024: $125 · 2025: $103.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $330.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $329.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotissue Holdings INC. | $1,059.91 | 2019-2025 | |
| Allergan, INC. | $438.47 | 2019-2021 | |
| Alcon Vision LLC | $392.84 | 2019-2025 | Clareon, Precision7 |
| Sun Pharmaceutical Industries INC. | $246.57 | 2019-2021 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $232.53 | 2019-2021 | |
| Abbvie INC. | $167.71 | 2022-2025 | Lumigan, Vuity |
| Novartis Pharmaceuticals Corporation | $145.97 | 2019-2022 | |
| Sight Sciences, INC. | $127.67 | 2020 | |
| Mallinckrodt Hospital Products INC. | $92.99 | 2020 | |
| Mallinckrodt Enterprises LLC | $79.53 | 2019 | |
| Kala Pharmaceuticals, INC. | $75.87 | 2019-2021 | |
| Shire North American Group INC | $72.88 | 2019 | |
| Oyster Point Pharma, INC. | $36.31 | 2022-2023 | Tyrvaya |
| Rxsight INC | $32.07 | 2024 | Rxsight Contact Lens, Light Adjustable Lens (Lal), Rxsight Injector Cartridge |
| Apellis Pharmaceuticals, INC. | $17.72 | 2023 | Syfovre |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aerie Pharmaceuticals, INC. | $11.20 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Slama listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.